Question 1

What specific benefits can I expect from Erenumab compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine clinical trial (NCT04825678). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my treatment satisfaction be measured during this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine clinical trial (NCT04825678). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of using Erenumab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine clinical trial (NCT04825678). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for injections or check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine clinical trial (NCT04825678). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any other treatment options I should consider alongside this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine clinical trial (NCT04825678). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I don't respond well to Erenumab during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine clinical trial (NCT04825678). Contact the study team or your healthcare provider for specific answers.

What this study is about